![Jan-Erik Nyström](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan-Erik Nyström is the founder of TIRmed Pharma AB, which was founded in 2018, where he holds the title of Chairman.
He currently holds the position of Director at Stiftelsen Gunnar Och Elsa Jaderlunds Minne.
Mr. Nyström's former positions include Chief Executive Officer at Alveiro AB and Independent Director at Sprint Bioscience AB. He received an undergraduate degree from the Royal Institute of Technology.
| Sociétés | Poste | Début |
|---|---|---|
TIRmed Pharma AB
 TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology Develops topical eczema treatment solutions | Fondateur | 01/01/2018 |
Stiftelsen Gunnar Och Elsa Jaderlunds Minne | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Alveiro AB | Directeur Général | - |
| SPRINT BIOSCIENCE AB | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprint Bioscience AB
 Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Alveiro AB | |
TIRmed Pharma AB
TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology Develops topical eczema treatment solutions | Health Technology |
Stiftelsen Gunnar Och Elsa Jaderlunds Minne |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
